China's ZhenGe Biotech banks $51m in Series A round

China's ZhenGe Biotech banks $51m in Series A round

Laboratory equipment. Photo: Pixabay

30 March, 2020

CDMO Lyfe Capital pharmaceutical ZhenGe Biotech

Printed by Unregistered user on Tue, 22 Jul 2025 14:50:26 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese biotech startup IASO closes $60m Series B round led by GL Ventures

Chinese biotech startup GenFleet closes $58m in Series B round

Read more from Greater China

Venture Capital

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation